|
About TRAXION Therapeutics, Inc.
Traxion Therapeutics Inc. is a biotech company focused
on the development of novel drugs for the treatment of intractable pain,
specifically neuropathic pain.
Traxion has assembled a diversified portfolio of
novel, proprietary small molecule products to address this market
opportunity. These products use more selective, mechanism-based
approaches which exploit recent scientific discoveries in order to
develop more effective, better tolerated treatments for neuropathic pain.
Traxion’s experienced team plans to take these
products through to Phase II proof of concept studies and then enter
worldwide corporate partnerships for later-stage development and
commercialization.
Related links
www.neuropathy.org
www.ampainsoc.org
|
